Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Alenwel 70
Alenwel 70 (Alendronate Sodium 70 mg) is a clinically proven medication for osteoporosis management and bone health preservation. As a bisphosphonate, it helps reduce bone loss, increase bone density, and lower the risk of fractures, making it an essential treatment for individuals prone to osteoporosis-related complications.
Uses of Alenwel 70
Treatment and prevention of osteoporosis in postmenopausal women.
Management of osteoporosis in men to reduce fracture risk.
Treatment of glucocorticoid-induced osteoporosis.
Management of Paget’s disease of bone.
Benefits of Alenwel 70
Effectively increases bone mineral density.
Reduces the incidence of vertebral and non-vertebral fractures.
Long-term safety and efficacy in osteoporosis management.
Convenient once-weekly oral administration for improved compliance.
Mechanism of Action of Alenwel 70
Alenwel 70 (Alendronate Sodium) inhibits osteoclast-mediated bone resorption by binding to hydroxyapatite in bone. This action slows down bone loss while maintaining bone formation, leading to increased bone strength. By reducing bone turnover, Alenwel 70 enhances skeletal integrity, helping patients maintain mobility and overall bone health.